Non-small cell lung cancer (NSCLC) patients with the metastatic spread of disease to the bone have high morbidity and mortality. Stereotactic ablative body radiotherapy increases the progression free survival and overall survival of these patients with oligometastases. FDG-PET/CT, a functional imaging technique combining positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) and computer tomography (CT) provides improved staging and identification of treatment response. It is also associated with reduction in size of the radiotherapy tumour volume delineation compared with CT based contouring in radiotherapy, thus allowing for dose escalation to the target volume with lower doses to the surrounding organs at risk. FDG-PET/CT is increasingly being used for the clinical management of NSCLC patients undergoing radiotherapy and has shown high sensitivity and specificity for the detection of bone metastases in these patients. Here, we present a software tool for detection, de
FAIRFAX, VA (PRWEB) July 25, 2022 Cardiac imaging specialist and cardiac amyloidosis researcher Sharmila Dorbala, MD, MPH, MASNC, will present the Mario
AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of amyloidSensitivity in those with previously diagnosed cardiac.